Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.58M | -1.25M | -1.13M | -955.80K | -1.00M |
| Total Depreciation and Amortization | 1.10K | 1.20K | 1.30K | 1.40K | 1.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 539.00K | 350.30K | 344.40K | 295.90K | 291.40K |
| Change in Net Operating Assets | -13.30K | 676.10K | 530.10K | 354.10K | 189.60K |
| Cash from Operations | -1.05M | -224.30K | -249.70K | -304.50K | -518.70K |
| Capital Expenditure | -123.50K | -121.80K | -120.40K | -121.30K | -126.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -123.50K | -121.80K | -120.40K | -121.30K | -126.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.62M | 499.20K | 499.20K | 510.00K | 510.00K |
| Repurchase of Common Stock | -5.60K | -5.60K | -18.10K | -18.10K | -16.40K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 447.30K | 138.10K | 21.40K | -28.90K | -25.30K |
| Cash from Financing | 1.44M | 467.50K | 373.50K | 345.00K | 348.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 267.90K | 121.40K | 3.40K | -80.90K | -296.30K |